
Richard Moffat sits down with Reto Suter, CFO of Siegfried, for the final instalment of our Live from the Nice Conference series. As Reto hands over the baton of CFO, he reflects on nearly a decade at one of Europe's fastest-growing CDMOs, discussing the power of long-term compounding, the structural growth drivers shaping the pharmaceutical industry, and why investors often underestimate the value of steady execution. The conversation explores how innovation is increasingly being driven by small and mid-sized biotech companies, the role of AI in transforming drug development and manufacturing, and how trends such as supply chain localisation and the rapid growth of GLP-1 therapies are creating new opportunities for the sector. Hosted on Acast. See acast.com/privacy for more information.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Alex Irving: European Airlines, Ready for Take Off

Live from the Nice Conference: Gerrit Steen, CFO of AT&S

Live from the Nice Conference: Ian Malin, CCO of Wizz Air

Nadine Sarwat: A $20+ Cocktail... In This Economy?
Free AI-powered recaps of In the Know and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.